STRO vs TEL
Sutro Biopharma (STRO) versus TE Connectivity Ltd (TEL) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
TE Connectivity Ltd (TEL) is a electronic components company listed on US.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported TEL revenue for 2025-09-26 was $17.26B. Net income was $1.84B. Revenue was up 8.9% from 2024-09-27 to 2025-09-26. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
STRO currently screens at market cap $470.8M. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
Not investment advice. Open the STRO and TEL stock pages for the full models.
Not investment advice.